Tm. Bauer et Aj. Bircher, DRUG-INDUCED HEPATOCELLULAR LIVER-INJURY DUE TO BENZYLPENICILLIN WITHEVIDENCE OF LYMPHOCYTE SENSITIZATION, Journal of hepatology, 26(2), 1997, pp. 429-432
Background/Aims: Reports on drug-induced liver injury due to benzylpen
icillin are scarce and predominantly describe cases of intrahepatic ch
olestasis. To our knowledge, no immunologically documented case of hep
atocellular liver injury due to benzylpenicillin has been reported so
far. Case Report: A previously healthy man required longterm therapy w
ith benzylpenicillin because of vertebral spondylitis. After 4 weeks o
f treatment, liver tests showed a marked increase in transaminases ass
ociated with high peripheral eosinophil counts, Discontinuation of ben
zylpenicillin resulted in gradual recovery. Investigations: Levels of
eosinophil cationic protein were elevated, indicating eosinophil activ
ition and the presence of an immunoallergic reaction. Skin tests and a
ssays for specific Ig E-antibodies to benzylpenicillin were negative,
but lymphocyte transformation tests demonstrated T-cell sensitization
to benzylpenicillin. Conclusions: According to current causality asses
sment schemes, our report constitutes a probable case of drug-induced
hepatocellular liver injury due to benzylpenicillin.